Bankruptcy Trustee in Zombie Lab Scandal Seeks $41-million in Paybacks The suits unveil the massive scope and sordid details about the kickback scheme Jun 13, 2017
CardioBrief: Serious Questions Raised About Validity Of International Trials TOPCAT analysis is the 'smoking gun' for trouble from 'offshoring' trials Apr 26, 2017
CardioBrief: SPRINT Leader Defends Controversial BP Trial Debate continues over methods, meaning of 'landmark' trial Apr 21, 2017
ACC: Another HDL Therapy Crashes and Burns Failure of pre-beta HDL mimetic puts another nail in the HDL coffin Mar 19, 2017
ACC: FOURIER Substudy May Help Refute 'Dr. Google' No neurocognitive adverse effects linked to very low LDL levels Mar 19, 2017
ACC: Novel Drug Delivers Long-Term Cholesterol Reduction RNA interference drug inhibits synthesis of PCSK9 Mar 18, 2017
Scott Gottlieb's Sham Ideology Rejects Clinical Trials The next FDA commissioner doesn't believe in trials with sham controls Mar 14, 2017
Top Cardiologist Blasts Nutrition Guidelines Salim Yusuf says new evidence fails to support many major diet recommendations. Feb 27, 2017
CardioBrief: Int'l Experts Call Sodium Guidelines Far Too Restrictive Conclusion: research more, recommend less Feb 14, 2017
Um, Excuse Me, Why Did You Stop My Post-Op Anticoagulant? Cardiology writer learns firsthand about real-world practice Jan 29, 2017
Novartis Pulls Out of Controversial Entresto Contest Cardiologists named to review panel had quit Dec 19, 2016
CardioBrief: Prenatal Genetic Test Billing Practices Questioned Insurance billed $2,760, but is the "real" bill $200? Nov 29, 2016
AHA: Mixed Results For ApoA-1 Therapies But it's still not time to write the obituary for all HDL therapies Nov 16, 2016
CardioBrief: Is the American Heart Association Trying to Kill Reporters? Margarine and skim milk in the press room beg the question Nov 15, 2016
Statin 'Census' Shows Major Disparities Women, minorities treated at significantly lower rates Nov 14, 2016
AHA: No Cognitive Benefit from Heart Drugs in HOPE-3 Substudy finds mental function unimproved by BP, cholesterol treatments Nov 13, 2016 video
AHA: Long-Term Benefit in HF Patients Elusive for Novel Vasodilator Investigational drug ularitide had no effect on mortality or clinical outcomes Nov 13, 2016
CardioBrief: Impella No Better Than IABP in Cardiogenic Shock Underpowered IMPRESS trial shows no mortality benefit Oct 30, 2016
CardioBrief: LDL-Lowering Genetic Variants Linked to Diabetes Risk What can genetics tell about diabetes incidence with cholesterol tx? Oct 06, 2016
CardioBrief: Trump's CV Event Risk Seven Times Bigger Than Clinton's Cardiologist speculates on coronary calcium scores disclosed by the candidates Oct 05, 2016
Billion Dollar Lab Scam: The Beat Goes On Yet more fallout from the catastrophic bankruptcy of HDL Lab Sep 22, 2016
The Lancet Versus BMJ: A Dispatch From the Statin Wars The editors of the two top U.K. medical journals are in a bitter fight Sep 15, 2016
How Sweet: Sugar Industry Made Fat the Villain Harvard researchers received sugar industry money to write a NEJMreview Sep 12, 2016
JACC Retracts AF Ablation Trial Lead author Andrea Natale claims undue industry influence Sep 11, 2016
CardioBrief: Cardiologists Give SPRINT Thumbs Down Trial should not be used in guidelines to lower blood pressure targets Aug 29, 2016
CardioBrief: Changes in Eskimo Diet Linked to Increase in CHD Shift could explain apparently contradictory evidence on fats, carbs Aug 01, 2016
The Billion Dollar Lab Scandal Part one: the rise and fall of Health Diagnostics Laboratory Jul 15, 2016
CardioBrief: Prominent Cardiologist Found Guilty of Fraud Karl-Heinz Kuck is also running for ESC president Jun 07, 2016
The American Heart Association's Stance Against Science Group insists dietary sodium question is settled when it plainly isn't May 27, 2016
CardioBrief: You Say Potato, I Say Worthless Epidemiology Observational study links potatoes to high blood pressure May 17, 2016
On Road to Bankruptcy Stent Maker Invested in Marty Leon's VC Fund More questions about company founded by stent pioneer Julio Palmaz May 04, 2016
CardioBrief: Diet Drug Loses Another Cardiovascular Outcomes Trial More chaos over the weight loss drug Contrave Apr 13, 2016
ACC: After a Decade, CABG Pulls Ahead of Meds for HF Life-saving benefit of CABG now clear in long-term trial follow-up Apr 04, 2016
CardioBrief: Top HF Expert Decries 'Unbelievable Folly' of Clinical Trials and Guidelines Milton Packer, MD, calls the system to test and evaluate heart failure drugs dysfunctional Mar 23, 2016
CardioBrief: LVADs Prolong Life But Sow Confusion at Its End Uncertainty dogs heart pump patients and their caregivers Mar 22, 2016
CardioBrief: New Thinking on Primary Prevention, Death, and Statins Could lifetime benefit replace 10-year cardiovascular risk in shared decision-making? Mar 18, 2016
CardioBrief: Entresto Maker in Deep Water Over Terrifying TV Ad "Alarmist," "horrifying" and "irresponsible," experts say Feb 03, 2016
CardioBrief: Entresto Off to Slow Start 'Blockbuster' heart failure drug falls short of already low sales expectations Jan 29, 2016
CardioBrief: 'Walking Time Bombs' Is this fear mongering or effective communication of risk? Nov 05, 2015
